Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 146 participants.
Also called NCT01541865
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 146 participants
- Sponsor
- Registry
-
NCT01541865
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Australia, Austria, Belgium, France, Germany, Netherlands, New Zealand, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01541865. Allocation not applicable; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-11 (actual). Results posted on 2015-10-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter
- Acronym
- REDUCE-HTN
- Condition
- Hypertension
- Intervention (Device)
- Renal Denervation
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01541865- Content hash
807b032b5c4e358944081b82c8f49cbdd765fc5cd28153587cb76d6e4ed81713